Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Reuters NEXT Gulf leadership summit to return with Abu Dhabi Department of Economic Development as exclusive host city partner for next three years

    August 21, 2026

    Thumbay International Pathway – MD Program, With Installments and a Direct Route to Residency in Romania

    August 21, 2026

    STARTRADER Launches XAUUSD247, Extending Gold CFD Access Across the Full Week

    August 21, 2026
    Facebook X (Twitter) Instagram
    Arab BulletinArab Bulletin
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Arab BulletinArab Bulletin
    Home » Thumbay to Launch UAE’s First-of-Its-Kind Academic Programs in Longevity Medicine in Partnership with Switzerland’s Geneva College of Longevity Science
    Featured News

    Thumbay to Launch UAE’s First-of-Its-Kind Academic Programs in Longevity Medicine in Partnership with Switzerland’s Geneva College of Longevity Science

    July 11, 2026
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Newszy: Ajman, July 2026 – Thumbay Group, has signed a landmark Memorandum of Understanding (MoU) with the Geneva College of Longevity Science (GCLS), Switzerland, becoming the first private medical university in the United Arab Emirates to introduce structured academic education in Longevity Medicine, Healthy Ageing, Preventive Healthcare, and Precision Health — delivered through the newly established Thumbay Institute of Longevity Medicine.

    The partnership brings together GCLS, the world’s first higher education institution dedicated exclusively to longevity science, and Gulf Medical University’s internationally recognised academic excellence, backed by the extensive clinical ecosystem of Thumbay Healthcare — creating a unique platform for advancing longevity education, research, innovation, and professional development across the Middle East.

    This strategic collaboration supports the UAE’s vision of becoming a global hub for advanced healthcare, preventive medicine, and medical innovation, while positioning the UAE and the wider GCC as emerging leaders in longevity medicine.

    As part of the collaboration, the Thumbay Institute of Longevity Medicine will launch six internationally developed professional certificate programmes in academic partnership with GCLS. Each programme will be delivered in a hybrid format over three months, with an initial intake of approximately 100 participants per programme:

    1. Thumbay Professional Certificate in Clinical Longevity Medicine
    2. Thumbay Professional Certificate in Longevity Physiotherapy
    3. Thumbay Professional Certificate in Longevity Nutrition
    4. Thumbay Professional Certificate in Longevity Fitness
    5. Thumbay Professional Certificate in Peptide Medicine
    6. Thumbay Professional Certificate in Artificial Intelligence in Healthcare

    Designed for physicians, pharmacists, nurses, physiotherapists, nutritionists, fitness professionals, and other allied healthcare practitioners, the programmes combine Swiss academic expertise with GMU’s educational excellence, clinical faculty, simulation facilities, and integrated Academic Health System.

    Participants will benefit from internationally benchmarked curricula developed by GCLS, supported by visiting international faculty and regional clinical experts, with clear academic progression pathways into advanced studies in longevity science.

    GCLS’s 2026 Global Longevity Physician Survey, drawing responses from physicians across six continents, found that 99% of longevity physicians report rising patient demand — with 44% reporting growth of more than 50% in just three years. 83% believe healthcare will shift decisively toward prevention, and 76% expect major lifespan extension to become realistic within 20 years.

    Dr. Thumbay Moideen, Founder President, Thumbay Group:

    “By joining hands with the Geneva College of Longevity Science, we are bringing world-class Swiss academic standards to the UAE and giving healthcare professionals across the Gulf the training this new era demands. Our vision is to make Gulf Medical University From the No. 1 Private Medical University in the Gulf to the leading institute in the World.”

    Dr. Dominik Thor, President, Geneva College of Longevity Science:

    “Longevity medicine is becoming an essential component of modern healthcare, but the field urgently needs education, clinical standards, and credible training infrastructure. Through partnerships with leading universities, GCLS is helping to establish the academic foundations globally and Gulf Medical University is the ideal partner to build that infrastructure in the Middle East.”

    The MOU establishes a phased collaboration beginning with education and professional development, with scope to expand into co-branded conferences, workshops, symposiums, and further joint activities as the partnership matures. All programs introduced will have UAE accreditation — ensuring full compliance with the UAE Ministry of Education’s Commission for Academic Accreditation and relevant health authorities.

    Admission are open for the 26-27 Batch of students with over 50 Programs and Applications for the first cohort open ahead of the September/October 2026 intake. Details will be available at www.gmu.ac.ae

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email

    Related Posts

    Featured News August 21, 2026

    Thumbay International Pathway – MD Program, With Installments and a Direct Route to Residency in Romania

    Featured News August 19, 2026

    SOUEAST UAE launches S08 Luxury following the success of the Flagship S08DM

    Featured News August 18, 2026

    Thumbay Group and UMFST G.E. Palade Targu Mures, Romania Launch Thumbay – UMFST International Residency Pathway Program, Opening the Door to 49 European Medical Specialties

    Featured News August 9, 2026

    KoçSistem Leads Türkiye’s IT System Integrator for the Eighth Consecutive Year as KoçDigital Wins Top AI Award

    Featured News August 7, 2026

    Papa Johns teams up with Disney and Pixar for Toy Story 5

    Featured News July 25, 2026

    Excellence in Dental Education: Gulf Medical University’s College of Dentistry Sets the Clinical Benchmark with 120 Dental Chairs and a Dedicated Teaching Hospital

    Latest News
    Business August 20, 2026

    Wall Street rises after Treasury expands debt buybacks

    Healthcare shares strengthen market gains
    Healthcare stocks provided another source of support during Wednesday’s session as several pharmaceutical shares recorded large gains. Moderna shares surged 177%, while Merck advanced 12.6% after the companies announced positive results from a Phase 3 melanoma trial. The INTerpath-001 study tested personalized mRNA therapy intismeran autogene with Keytruda following surgical removal of high-risk melanoma. The combination met its primary endpoint for recurrence-free survival. It also met a key secondary endpoint measuring survival without distant cancer spread.

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026

    Indonesia 6.1 earthquake rattles North Sumatra coast

    August 19, 2026

    DRC malaria cases surpass 26 million in 2025

    August 17, 2026

    DRC Ebola outbreak sets national death toll record

    August 17, 2026

    South Korea auto exports reach $6.24 billion in July

    August 14, 2026
    © 2026 Arab Bulletin | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.